Novonesis (formerly Chr. Hansen)
Danish biosolutions company supplying probiotic cultures, enzymes and human milk oligosaccharides.
- MOQ
- Not publicly disclosed
- LEAD TIME
- Not publicly disclosed
Overview
Novonesis is a Danish biosolutions company formed from the January 2024 merger of Chr. Hansen (founded 1874) and Novozymes. Headquartered in Hoersholm, Denmark, the combined company has approximately 10,000 employees worldwide and EUR 3.7 billion in annual revenue. The health and nutrition division supplies probiotic cultures, bacterial strains, enzymes, and human milk oligosaccharides (HMOs) to the global dietary supplement and food industries. Chr. Hansen's 150-year legacy in bacterial cultures makes Novonesis one of the world's largest culture collections for probiotic applications. The company operates US production facilities for probiotics.
Certifications
Certification verification in progress. International supplier records require regional database lookups (EudraGMDP, Health Canada NHP, FSSC public register, JHFA directory). See our methodology.
Capabilities
- PRODUCT TYPES
- Probiotic Cultures & Strains · Bacterial Cultures · Enzymes · Human Milk Oligosaccharides (HMOs)
- CAPABILITIES
- Clinical research or study support · Probiotics or postbiotics · Enzymes · Fibers, prebiotics or functional carbohydrates · US production
Sources
What we couldn't verify
We did not visit this company on site. See the limits that apply to every listing.
- Headquarters in Denmark; additional manufacturing in multiple countries including US
- Company underwent major merger (Chr. Hansen + Novozymes) in January 2024. Integration still in progress
- Very large conglomerate (EUR 3.7B revenue). Dietary supplement ingredients are one division among many
- Certification details beyond cGMP not independently verified from public databases
Dietary supplement manufacturers must comply with 21 CFR Part 111 (cGMP). What Part 111 requires
The connection map between Novonesis (formerly Chr. Hansen) and other vendors, capabilities, and certifications is in the manufacturer atlas.
Enforcement screening: included in Inventory Ready's most recent completed pass against FDA's published recall datasets (2026-07-09). Method and limits →
Interested in Novonesis (formerly Chr. Hansen)?
Tell us about your project and we'll help you determine if this ingredient supplier is a good fit.